AMETEK, Inc. vs KLA Corporation, two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where AME and KLAC diverge most: on ev/ebitda, AME reads 23.9 and KLAC reads 1098.4; on p/b, AME reads 5.07 and KLAC reads 40.59. The rest of the comparable metrics sit closer together. What AME's price implies is a bet that sits within the historical range (whole-company basis). What KLAC's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | AME | KLAC |
|---|---|---|
| Price | $248.36 | $195.64 |
| Market cap | $57.1B | $257.8B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Growth | Mature |
| P/E | 36.3 | 17.1 |
| P/B | 5.07 | 40.59 |
| P/S | 7.26 | 18.98 |
| EV/EBITDA | 23.9 | 1098.4 |
| Revenue growth | +12.6% | +11.7% |
| Operating margin | 25.8% | — |
| Net margin | 20.0% | 35.6% |
| Return on equity | 14.0% | 76.1% |
| Return on assets | 9.5% | 26.9% |
| Return on invested capital | 12.7% | — |
| FCF yield | 3.2% | 1.5% |
| Dividend yield | 0.2% | 0.4% |
| Debt / equity | 0.18 | 0.93 |
| Current ratio | 1.21 | 2.88 |
| Altman Z (solvency) | 7.71 | 7.58 |
| Piotroski F (quality) | 8 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.